# MEDICUS PHARMA LTD \*W EXP 11/15/202

MEDICUS PHARMA LTD *W EXP 11/15/202 is a security (CUSIP 58471K111) tracked across SEC portfolio filings. 6 institutional managers reported $93K on Form 13F as of 2026-03-31.

## Summary

- Issuer: MEDICUS PHARMA LTD
- Class: \*W EXP 11/15/202
- CUSIP: 58471K111
- 13F holders: 6
- 13F value: $93K
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [ARMISTICE CAPITAL, LLC](https://search.stillhousedata.com/firm/168978) | NEW YORK, NY | $58K | 60,600 |
| Anson Funds Management LP | DALLAS, TX | $19K | 42,400 |
| [Empery Asset Management, LP](https://search.stillhousedata.com/firm/148180) | New York, NY | $11K | 12,100 |
| [Connective Capital Management, LLC](https://search.stillhousedata.com/firm/161099) | PALO ALTO, CA | $3K | 6,000 |
| UBS Group AG | Zurich, V8 | $820 | 1,465 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/58471K111.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.